- Home
- SOPA vs TOVX Comparison
SOPA vs TOVX Comparison
Compare SOPA & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- TOVX
- Stock Information
- Founded
- SOPA 2018
- TOVX 2001
- Country
- SOPA Singapore
- TOVX United States
- Employees
- SOPA N/A
- TOVX N/A
- Industry
- SOPA EDP Services
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- TOVX Health Care
- Exchange
- SOPA Nasdaq
- TOVX Nasdaq
- Market Cap
- SOPA 3.8M
- TOVX 4.5M
- IPO Year
- SOPA 2021
- TOVX 2006
- Fundamental
- Price
- SOPA $1.25
- TOVX $0.50
- Analyst Decision
- SOPA Strong Buy
- TOVX Hold
- Analyst Count
- SOPA 1
- TOVX 1
- Target Price
- SOPA $15.00
- TOVX N/A
- AVG Volume (30 Days)
- SOPA 106.3K
- TOVX 170.2K
- Earning Date
- SOPA 08-18-2025
- TOVX 08-12-2025
- Dividend Yield
- SOPA N/A
- TOVX N/A
- EPS Growth
- SOPA N/A
- TOVX N/A
- EPS
- SOPA N/A
- TOVX N/A
- Revenue
- SOPA $6,731,955.00
- TOVX N/A
- Revenue This Year
- SOPA N/A
- TOVX N/A
- Revenue Next Year
- SOPA $45.16
- TOVX N/A
- P/E Ratio
- SOPA N/A
- TOVX N/A
- Revenue Growth
- SOPA N/A
- TOVX N/A
- 52 Week Low
- SOPA $0.64
- TOVX $0.40
- 52 Week High
- SOPA $6.75
- TOVX $7.25
- Technical
- Relative Strength Index (RSI)
- SOPA 47.70
- TOVX 52.75
- Support Level
- SOPA $1.23
- TOVX $0.45
- Resistance Level
- SOPA $1.35
- TOVX $0.52
- Average True Range (ATR)
- SOPA 0.06
- TOVX 0.03
- MACD
- SOPA -0.00
- TOVX 0.01
- Stochastic Oscillator
- SOPA 45.45
- TOVX 77.78
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.